Abstract: Disclosed is a use of Combretum micranthum extract in cosmetics. Processes such as a solvent extraction method and a chromatographic method are specifically used, it is found that a Combretum micranthum plant or its extract has the effects of moisturizing, anti-inflammatory, post-sun repair, repair of skin barrier, repair of UV-induced DNA damage, whitening, fading spots and anti-glycation and the like. The prepared Combretum micranthum extract can be added into cosmetics as an active ingredient thereof. The cosmetic or drug containing the Combretum micranthum extract has the efficacies of moisturizing, anti-inflammatory, post-sun repair, repair of skin barrier, repair of UV-induced DNA damage, whitening, anti-freckle and resisting saccharification and the like, thereby achieving the effect of skin care and beauty.

Abstract: The disclosure provides seed, tissue cultures, essential oil extracts, and plants of catnip hybrid ‘CR3’, as well as methods for producing a catnip plants by crossing ‘CR3’plants with themselves or with another catnip plant, such as a plant of another genotype, variety, or cultivar. The disclosure further provides seed, tissue cultures, essential oil extracts, and plants produced by such crossing. Methods of using the plants and extracts as insect repellents and in pet toys, are also provided.

Abstract: The disclosure provides seed, tissue cultures, essential oil extracts, and plants of catnip hybrid ‘CR3’, as well as methods for producing a catnip plants by crossing ‘CR3’plants with themselves or with another catnip plant, such as a plant of another genotype, variety, or cultivar. The disclosure further provides seed, tissue cultures, essential oil extracts, and plants produced by such crossing. Methods of using the plants and extracts as insect repellents and in pet toys, are also provided.

Abstract: The disclosure provides seed, tissue cultures, essential oil extracts, and plants of catnip hybrid ‘CR3’, as well as methods for producing a catnip plants by crossing ‘CR3’ plants with themselves or with another catnip plant, such as a plant of another genotype, variety, or cultivar. The disclosure further provides seed, tissue cultures, essential oil extracts, and plants produced by such crossing. Methods of using the plants and extracts as insect repellents and in pet toys, are also provided.

Abstract: The disclosure provides seed, tissue cultures, essential oil extracts, and plants of catnip hybrid ‘CR3’, as well as methods for producing a catnip plants by crossing ‘CR3’ plants with themselves or with another catnip plant, such as a plant of another genotype, variety, or cultivar. The disclosure further provides seed, tissue cultures, essential oil extracts, and plants produced by such crossing. Methods of using the plants and extracts as insect repellents and in pet toys, are also provided.

Abstract: The present invention relates to a novel use of naturally occurring plants, mushroom, extracts thereof that exhibit properties as HCV NS5B polymerase inhibitors.

Abstract: This invention provides the methods of separation and identification of a novel type of piperidine flavan alkaloids from an African herbal tea, the leaves of Combretum micranthum commonly known as kinkeliba, and the procedures for preparing the total piperidine flavan alkaloids (TPFA). In particular, this invention relates to the use of the plant extract that may contain TPFA as anti-diabetic agents in treatment of metabolic disorders and other applications related to this new chemical structure and derivatives thereof.

Abstract: The present invention relates to a novel use of naturally occurring plants, mushroom, extracts thereof that exhibit properties as HCV NS5B polymerase inhibitors.

Abstract: This invention provides the methods of separation and identification of a novel type of piperidine flavan alkaloids from an African herbal tea, the leaves of Combretum micranthum commonly known as kinkeliba, and the procedures for preparing the total piperidine flavan alkaloids (TPFA). In particular, this invention relates to the use of the plant extract that may contain TPFA as anti-diabetic agents in treatment of metabolic disorders and other applications related to this new chemical structure and derivatives thereof.

Abstract: The present invention relates to bioactivity-guided isolation and identification of bioactive compounds from oregano and mint plants, in particular, rosmarinic acid, oleanolic acid and ursolic acid, and use of these compounds or combinations thereof as anti-inflammatory agents for the treatment of conditions related to pain and inflammation and/or as ingredients of dietary supplements. The invention also relates to optimization of the methods for qualitative and quantitative analysis of the bioactive compounds in oregano and mint plants. In particular, this invention introduces an LC/MS (SIM mode) method to achieve co-quantitation of the three organic acids using a unique tandem column system. In addition, the invention also relates to the methods for recovering various water-soluble polyphenols and triterpenes from aromatic plants.